Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by ER Shilova
Thrombopoietin Receptor Agonists in Treatment of Idiopathic Thrompocytopenic Purpura (Primary Immune Thrombocytopenia): Efficacy and Safety in Everyday Clinical Practice
Klinicheskaya Onkogematologiya/Clinical Oncohematology
Oncology
Hematology
Related publications
Use of Thrombopoietin Receptor Agonists in Childhood Immune Thrombocytopenia
Frontiers in Pediatrics
Child Health
Pediatrics
Perinatology
A United Kingdom Immune Thrombocytopenia (ITP) Forum Review of Practice: Thrombopoietin Receptor Agonists
British Journal of Haematology
Hematology
Thrombopoietin Receptor Agonists for the Treatment of Inherited Thrombocytopenia
Haematologica
Hematology
The Emergence of Thrombopoietin Receptor Agonists as a Novel Treatment for Immune Thrombocytopenia
European Oncology and Haematology
Oncology
Hematology
Switching Thrombopoietin Receptor Agonist Treatments in Patients With Primary Immune Thrombocytopenia
Therapeutic Advances in Hematology
Hematology
Eltrombopag, a Thrombopoietin- Receptor Agonist in the Treatment of Adult Chronic Immune Thrombocytopenia: A Review of the Efficacy and Safety Profile
Therapeutic Advances in Hematology
Hematology
Relative Potency of the Thrombopoietin Receptor Agonists Eltrombopag, Avatrombopag and Romiplostim in a Patient With Chronic Immune Thrombocytopenia
British Journal of Haematology
Hematology
The Comparative Pharmacoeconomic Analysis of Using Different Agonists of the Thrombopoietin Receptor in Adult Patients With Chronic Idiopathic Thrombocytopenic Purpura in Actual Practice in Russia
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
PP025 Thrombopoietin Receptor Agonist for Treatment of Adults With Chronic Immune Thrombocytopenic Purpura
International Journal of Technology Assessment in Health Care
Health Policy
